Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Antonella Isacchi, Arturo Galvani et al.|Molecular Cancer Therapeutics|2017Cited by 93
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1Roberta Bosotti, Antonella Isacchi, Paola Magnaghi et al.|Scientific Reports|2017Cited by 17
Supplementary Materials and Methods, Tables S1-S2, and Figures S1-S6 from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Antonella Isacchi, Barbara Salom et al.|Unknown|2023Cited by 0
Data from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Antonella Isacchi, Barbara Salom et al.|Unknown|2023Cited by 0
Data from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Antonella Isacchi, Barbara Salom et al.|Unknown|2023Cited by 0